These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 28395805)

  • 1. Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T.
    Ma D; Ng SH; Zeng L; Zhao Y; Tan EK
    Stem Cell Res; 2017 Jan; 18():54-56. PubMed ID: 28395805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene.
    Ma D; Zhou W; Ng EY; Zeng L; Zhao Y; Tan EK
    Stem Cell Res; 2017 Jan; 18():45-47. PubMed ID: 28395802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient carrying the N551K variant in LRRK2 gene.
    Ma D; Ng EY; Zeng L; Lim CY; Zhao Y; Tan EK
    Stem Cell Res; 2017 Jan; 18():51-53. PubMed ID: 28395804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation of human induced pluripotent stem cell (iPSC) line with LRRK2 gene R1398H variant in Parkinson's disease.
    Ma D; Tio M; Ng SH; Li Zeng ; Lim CY; Zhao Y; Tan EK
    Stem Cell Res; 2017 Jan; 18():48-50. PubMed ID: 28395803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient.
    Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H
    Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation.
    Lin HI; Cheng YC; Ko HW; Wen CH; Lu HE; Huang CY; Hsieh PCH; Lin CH
    Stem Cell Res; 2019 May; 37():101447. PubMed ID: 31029016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of human induced pluripotent stem cell (iPSC) line from a 60year old female patient with multiple schwannoma.
    Zhang S; Lv Z; Liu Y; Li Q; Gong W; Liu L; Wu H
    Stem Cell Res; 2017 Mar; 19():31-33. PubMed ID: 28413001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of MERRF patient-derived induced pluripotent stem cell line iMERRF-C7.
    Liang D; Hu H; Xu T; Wang Y; Hu P; Xu Z
    Stem Cell Res; 2016 Nov; 17(3):616-618. PubMed ID: 27934592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma.
    Zhang S; Lv Z; Hu Y; Liu L; Gong W; Li Q; Wu H
    Stem Cell Res; 2017 Mar; 19():49-51. PubMed ID: 28413006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant.
    Cheng YC; Huang CY; Ho MC; Hsu YH; Syu SH; Lu HE; Lin HI; Lin CH; Hsieh PCH
    Stem Cell Res; 2018 Apr; 28():1-5. PubMed ID: 29414410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene.
    Marote A; Pomeshchik Y; Collin A; Goldwurm S; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Apr; 28():44-47. PubMed ID: 29414418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of induced pluripotent stem cells from a patient with Parkinson's disease carrying LRRK2 p.I2012T mutation.
    Lin CH; Cheng YC; Lin HI; Ho MC; Hsu YH; Wen CH; Ko HW; Lu HE; Huang CY; Hsieh PCH
    Stem Cell Res; 2017 Dec; 25():123-127. PubMed ID: 29127874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human induced pluripotent stem cell (iPSC) line from a 72year old male patient with later onset Alzheimer's disease.
    Zhang S; Lv Z; Zhang S; Liu L; Li Q; Gong W; Sha H; Wu H
    Stem Cell Res; 2017 Mar; 19():34-36. PubMed ID: 28413002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of an induced pluripotent stem cell line from a Loeys-Dietz syndrome patient with transforming growth factor-beta receptor-2 gene mutation.
    Hu K; Li J; Zhu K; Chen J; Liu D; Wang Y; Sun Y; Lai H; Wang C
    Stem Cell Res; 2017 Apr; 20():115-117. PubMed ID: 28395736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of induced pluripotent stem cells (iPSCs) from a Bernard-Soulier syndrome patient carrying a W71R mutation in the GPIX gene.
    Lopez-Onieva L; Montes R; Lamolda M; Romero T; Ayllon V; Lozano ML; Vicente V; Rivera J; Ramos-Mejía V; Real PJ
    Stem Cell Res; 2016 May; 16(3):692-5. PubMed ID: 27346198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a human induced pluripotent stem cell (iPSC) line from a Bernard-Soulier syndrome patient with the mutation p.Asn45Ser in the GPIX gene.
    Lopez-Onieva L; Machuca C; Lamolda M; Montes R; Lozano ML; Vicente V; Rivera J; Ramos-Mejía V; Real PJ
    Stem Cell Res; 2016 Nov; 17(3):603-606. PubMed ID: 27934591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of EHMT1 mutant induced pluripotent stem cell (iPSC) line from a 11-year-old Kleefstra syndrome (KS) patient with autism and normal intellectual performance.
    Varga E; Nemes C; Táncos Z; Bock I; Berzsenyi S; Lévay G; Román V; Kobolák J; Dinnyés A
    Stem Cell Res; 2016 Nov; 17(3):531-533. PubMed ID: 27789404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson's disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 gene.
    Cheng YC; Lin HI; Syu SH; Lu HE; Huang CY; Lin CH; Hsieh PCH
    Stem Cell Res; 2019 May; 37():101432. PubMed ID: 30978640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of induced pluripotent stem cells from a patient with spinocerebellar ataxia type 3.
    Soong BW; Syu SH; Wen CH; Ko HW; Wu ML; Hsieh PC; Hwang SM; Lu HE
    Stem Cell Res; 2017 Jan; 18():29-32. PubMed ID: 28395798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of induced pluripotent stem cell (iPSC) line from 55-year old male patient with hemorrhagic Moyamoya disease.
    Cardano M; Marsoner F; Marcatili M; Karnavas T; Zasso J; Lanterna LA; Conti L
    Stem Cell Res; 2016 Nov; 17(3):623-626. PubMed ID: 27934594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.